VRCA · Verrica Pharmaceuticals Inc.
$4.97
+0.11 (+2.26%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists regarding its ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$87.44M
Shares
17.18M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-06 | Thursday, August 6, 2026 (4:30 pm ET) | Event |
| 2026-06-04 | Thursday, June 4, 2026 (11:05 am ET) | Event |
| 2026-05-19 | Tuesday, May 19, 2026 (1:30pm ET) | Event |
| 2026-05-15 | Friday, May 15, 2026 at 4:30 pm – 6:00 pm – Poster Number: LB1190 – VP-315 Demonstrates Potential Abscopal Effect in Untreated Non-Target Basal Cell Carcinoma (BCC) Tumors | Event |
| 2026-05-13 | May 13, 2026 | Event |
| 2026-05-12 | Tuesday, May 12, 2026 (4:30 pm ET) | Event |
| 2026-05-12 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-11 | Earnings conference call (announced in 8-K) | Earnings call |
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
42 filings
42 filers
Visit website
Investor relations